| |
| |
|
| Insider
Information: |
Peltz Stuart Walter |
| Relationship: |
Director |
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
189,223 |
|
|
Indirect Shares
|
54,903 |
|
|
| Direct
Value |
$6,225,007 |
|
|
|
Indirect Value
|
$1,996,273 |
|
|
| Total
Shares |
244,126 |
|
|
| Total
Value |
$8,221,280 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -511.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2023-01-31 |
166,962 |
2023-01-31 |
54,903 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-05 |
4 |
AS |
$50.33 |
$5,533,592 |
D/D |
(109,928) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-05 |
4 |
OE |
$10.85 |
$1,192,719 |
D/D |
109,928 |
166,013 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-18 |
4 |
AS |
$50.12 |
$314,979 |
D/D |
(6,284) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-18 |
4 |
OE |
$10.85 |
$68,181 |
D/D |
6,284 |
62,369 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
AS |
$50.00 |
$1,689,400 |
D/D |
(33,788) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
OE |
$10.85 |
$366,600 |
D/D |
33,788 |
89,873 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-07-15 |
4 |
AS |
$55.48 |
$5,570,151 |
D/D |
(100,000) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-07-15 |
4 |
OE |
$10.85 |
$1,085,000 |
D/D |
100,000 |
106,085 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-10-05 |
4 |
OE |
$10.85 |
$601,741 |
D/D |
55,460 |
110,645 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-10-05 |
4 |
AS |
$50.00 |
$2,773,000 |
D/D |
(55,460) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-10-06 |
4 |
AS |
$50.10 |
$6,233,083 |
D/D |
(124,351) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-10-06 |
4 |
OE |
$10.85 |
$1,368,902 |
D/D |
124,351 |
107,910 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-10-07 |
4 |
AS |
$52.94 |
$3,795,262 |
D/D |
(71,104) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-10-07 |
4 |
OE |
$10.85 |
$789,785 |
D/D |
71,104 |
104,260 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-11-02 |
4 |
AS |
$53.13 |
$2,682,954 |
D/D |
(50,000) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-11-02 |
4 |
OE |
$10.85 |
$542,500 |
D/D |
50,000 |
106,085 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-11-04 |
4 |
AS |
$60.00 |
$2,961,900 |
I/I |
(49,365) |
12,178 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-11-04 |
4 |
OE |
$11.23 |
$972,955 |
I/I |
38,328 |
20,599 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-12-07 |
4 |
AS |
$59.56 |
$21,254,766 |
D/D |
(348,417) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-12-07 |
4 |
OE |
$11.23 |
$7,894,942 |
D/D |
348,417 |
193,585 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-12-07 |
4 |
AS |
$59.52 |
$1,229,484 |
D/D |
(20,017) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-12-07 |
4 |
OE |
$10.85 |
$333,954 |
D/D |
20,017 |
63,293 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-12-30 |
4 |
AS |
$61.43 |
$17,641,459 |
D/D |
(285,718) |
56,085 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-12-30 |
4 |
OE |
$30.86 |
$9,067,681 |
D/D |
285,718 |
172,022 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-01-05 |
4 |
S |
$62.37 |
$87,443 |
D/D |
(1,402) |
54,683 |
0 |
% |
|
77 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
